Showing results (1311-1320 of 2,224) with videos related to

Sort By:
Pageof 223
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1988
Vasopressin gene expression in hypertensive, normotensive, and diabetes insipidus ratsJ T McCabe, K Almasan, E Lehmann, et al.
Parkinsonism & Related Disorders|June 15, 2015
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusionPaolo Solla, Alfonso Fasano, Antonino Cannas, et al.
Neurology|December 1, 1982
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugsR E Burke, S Fahn, J Jankovic, et al.
Der Nervenarzt|February 13, 2009
[Genetics of weight gain associated with antipsychotic medications]D J Müller, C Peter, I Puls, et al.
Nature|March 22, 2013
A syringe-like injection mechanism in Photorhabdus luminescens toxinsChristos Gatsogiannis, Alexander E Lang, Dominic Meusch, et al.
The International Journal of Neuropsychopharmacology|August 16, 2022
Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant PotentialAndrei-Nicolae Vasilescu, Natascha Pfeiffer, Federica Terraneo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2021
Expectations of Benefit in a Trial of a Candidate Disease-Modifying Treatment for Parkinson DiseaseTiago A Mestre, Eric A Macklin, Alberto Ascherio, et al.
Neurorehabilitation and Neural Repair|September 13, 2021
Upper Limb Performance in Daily Life Approaches Plateau Around Three to Six Weeks Post-strokeCatherine E Lang, Kimberly J Waddell, Jessica Barth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersDana N Broberg, Sandra E Black, Richard H Swartz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumDana N Broberg, Sandra E Black, Richard H Swartz, et al.
Pageof 223